Evidence map›Paper›PMID 38377146›Full record

ArticlePLoS genetics2024

TRPS1 modulates chromatin accessibility to regulate estrogen receptor alpha (ER) binding and ER target gene expression in luminal breast cancer cells.

Thomas G Scott, Kizhakke Mattada Sathyan, Daniel Gioeli, Michael J Guertin

Open access · goldAbstract read
In one paragraph

Article in PLoS genetics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Thomas G ScottDepartment of Biochemistry and Molecular Genetics, University of Virginia, Charlottesville, Virginia, United States of America.
Kizhakke Mattada SathyanCenter for Cell Analysis and Modeling, University of Connecticut, Farmington, Connecticut, United States of America.
Daniel GioeliDepartment of Microbiology, Immunology, and Cancer, University of Virginia, Charlottesville, Virginia, United States of America.
Michael J GuertinCenter for Cell Analysis and Modeling, University of Connecticut, Farmington, Connecticut, United States of America.ORCID 0000-0001-7148-3538
University of Connecticut · USUniversity of Virginia · US

Funding

MEDICAL SCIENTIST TRAINING PROGRAMT32GM007267 · NIGMS · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI GARCIA-BLANCO, MARIANO A. · 1985 to 2024
$13.4M
TRAINING IN CELL AND MOLECULAR BIOLOGYT32GM008136 · NIGMS · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI STUKENBERG, P. TODD · 1985 to 2020
$8.5M
Mechanisms of coordinate gene regulation by transcription factorsR35GM128635 · NIGMS · UNIVERSITY OF VIRGINIA · PI Michael Joseph Guertin · 2018 to 2026
$3.4M
NIGMS NIH HHS R35 GM128635NIGMS NIH HHS T32 GM007267NIGMS NIH HHS T32 GM008136
6 · The paper itself

Abstract

Common genetic variants in the repressive GATA-family transcription factor (TF) TRPS1 locus are associated with breast cancer risk, and luminal breast cancer cell lines are particularly sensitive to TRPS1 knockout. We introduced an inducible degron tag into the native TRPS1 locus within a luminal breast cancer cell line to identify the direct targets of TRPS1 and determine how TRPS1 mechanistically regulates gene expression. We acutely deplete over 80 percent of TRPS1 from chromatin within 30 minutes of inducing degradation. We find that TRPS1 regulates transcription of hundreds of genes, including those related to estrogen signaling. TRPS1 directly regulates chromatin structure, which causes estrogen receptor alpha (ER) to redistribute in the genome. ER redistribution leads to both repression and activation of dozens of ER target genes. Downstream from these primary effects, TRPS1 depletion represses cell cycle-related gene sets and reduces cell doubling rate. Finally, we show that high TRPS1 activity, calculated using a gene expression signature defined by primary TRPS1-regulated genes, is associated with worse breast cancer patient prognosis. Taken together, these data suggest a model in which TRPS1 modulates the genomic distribution of ER, both activating and repressing transcription of genes related to cancer cell fitness.

Indexed as

Breast NeoplasmsChromatinFingersHair DiseasesLanger-Giedion SyndromeNoseEstrogen Receptor alphaFemaleGATA Transcription FactorsGene ExpressionGenes, cdcHumansRepressor ProteinsChromatinESR1 protein, humanEstrogen Receptor alphaGATA Transcription FactorsRepressor ProteinsTRPS1 protein, human

Identifiers

PMID38377146
PMCPMC10906895
OpenAlexW4391952895

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.